Posted: Dec 7, 2009 11:52 AM by Carina Corral
Updated: Dec 7, 2009 11:52 AM
A team of researchers at the University of California, Santa Barbara's Burnham Institute for Medical Research have identified a peptide that could lead to "substantial improvements in cancer treatment."
The team, led by Erkki Ruoslahti, M.D., Ph.D., identified the peptide (a chain of amino acids) that specifically recognizes and penetrates cancerous tumors but not normal tissues.
This new peptide, called iRGD, could dramatically enhance both cancer detection and treatment.
"In our animal studies, the iRGD peptide has increased the efficacy of a number of anti-cancer drugs without increasing their side effects," said Dr. Ruoslahti. " If these animal experiments translate into human cancers, we would be able to treat cancer more effectively than before, while greatly reducing the side effects the patient would suffer."
The work is being published Dec. 9 in the journal Cancer Cell.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at firstname.lastname@example.org, and include the name of the story and information on the comment.
Thank you! KSBY.com
Get deals up to 80% off here!
Find the lowest gas prices in your area
Submit your photos to KSBY
Check out our calendar of events
Save with Hot Deals across our counties!
Events across the Central Coast
Follow The CW5 on Facebook.
The KSBY online public file.
What do you think? Leave us your feedback.
KSBY is your official CA Lottery station for San Luis Obispo and Santa Barbara Counties